Aide sur des tableurs

New vaccine support (NVS) for HPV

GAVI’s support for new vaccines presents an opportunity for countries to not only implement vaccines that protect against diseases causing substantial morbidity and/or mortality, but also to build upon the vaccine investments in order to increase immunisation coverage rates, and strengthen routine immunisation services and primary health care systems. In line with a 2009 WHO position paper on cervical cancer recommending that routine human papillomavirus (HPV) vaccination be included in national immunisation programmes, GAVI provides support to eligible countries for HPV vaccines that protect against types 16 and 18, responsible for causing about 70% of cervical cancer cases. The form of support provided by GAVI depends on the level of demonstrated ability in a country to deliver vaccines to young adolescent girls. Countries that have demonstrated the ability may apply for GAVI support for nationwide introduction of HPV vaccines.

ID Projet

47122-1920-LBR-19B-X

Statut de l'activité

2 - Implementation

Type d'aide

B02 - Contributions aux budgets réguliers des institutions multilatérales

% to Libéria

100.00

Organisations

Funding

The Global Alliance for Vaccination and Immunisation

Extending

World Health Organisation - core voluntary contributions account (for technical assitance)

Accountable

Federal States & Local Governments

Implementing

Federal States & Local Governments

Extending

United Nations Childrens Fund

Code CRS	%
Lutte contre les maladies infectieuses (12250)	100.0